Status:
RECRUITING
Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The general objective of this retrospective and prospective study is to evaluate the diagnostic and prognostic role of a quantitative analysis of PET images with 18F-PSMA in all stages of the disease ...
Detailed Description
In this study, all PET images with 18F-PSMA will be considered, but also the CT or MR images associated with them to allow better anatomical localization. This study will allow us to investigate the ...
Eligibility Criteria
Inclusion
- adult male patients;
- patients with histopathological diagnosis of prostate cancer undergoing staging or restaging;
- patients with clinical indication for PET examination with 18 F-PSMA;
Exclusion
- medical conditions that do not allow the acquisition of PET images;
- allergic reactions to iodinated contrast medium or creatinine levels \>2mg/dL.
Key Trial Info
Start Date :
October 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 13 2027
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06167629
Start Date
October 13 2022
End Date
July 13 2027
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRC
Milan, Italy